Brookfield: 16.5 times distributable earnings and a hold at $39.50

Brookfield Corporation earned $5.65 billion of distributable earnings before realizations over the twelve months to June 30, 2026, or $2.39 a share, and $6.17 billion, or $2.61 a share, once realized carried interest is added. The business is a collection of three engines: an asset manager that charges fees and earns carried interest, an insurance and annuity group, and a set of operating businesses. The shares already pay for all three at a growth rate that I find hard to underwrite with a margin of safety.

At $39.50 on October 29, 2026, the shares trade 23.4% above my Base value of $32.00, so the Base is 19.0% below the price. The Bear value of $22.17 is 43.9% below the price and the Bull value of $42.15 is 6.7% above it. I assign no probabilities to the cases. The required margin of safety of 35% gives a buy range of $19.40 to $22.89 and a conservative limit of $19.40. For existing holders this is a hold, and nothing here says to sell. For new money it is a watchlist name.

Valuation route: Holding company and conglomerate, valued on distributable earnings. Economic classification: Quality Growth to Compounder, with growth and the return on reinvested capital partly estimated. Primary method: ten years of distributable earnings converted to cash flow to shareholders, with the capital that growth consumes deducted, plus a separate value for realized carried interest. Cross-check: 14 times current distributable earnings before realizations. Values are present fair-value estimates, not 12-month price targets.

What Brookfield is

Brookfield Corporation owns a controlling stake in Brookfield Asset Management, the manager of alternative assets. It also owns Brookfield Wealth Solutions, a retirement-services and insurance group, and holds majority or large stakes in operating businesses across infrastructure, renewable power and property. The company reports one profit measure that ties them together: distributable earnings, which counts fees, spread earnings, distributions from operating businesses and realized carried interest, and is stated after corporate costs, corporate interest and preferred dividends.

That measure is not an accounting profit. It is a management definition, and it leaves out unrealized gains and losses that flow through net income. I use it because it is the figure the company manages to and because it is the closest thing to cash that the businesses send up to the parent. The weakness is that it relies on the company's own definition of what is distributable, so I keep a larger margin of safety than I would for a simpler business.

I value the group as one earnings stream and do not run a sum of the parts. The listed stakes trade at their own multiples, but a separate sum of the parts adds a second layer of assumptions about control premiums and the discount a holding company deserves, and it would not be independent of the earnings approach.

The latest quarter

The second quarter of 2026 is the latest reported period. The third quarter report is scheduled for November 12, 2026, so this analysis will be out of date on that day.

The three segments contribute roughly 47%, 28% and 25% of segment earnings over the last twelve months. Segment lines are shown before corporate costs, interest and preferred dividends, so they do not add to the totals above, and I use the reported totals throughout. Corporate interest was $189 million in the second quarter and $372 million in the first half of 2026.

What the earnings are made of

Three features decide how much of the $2.39 I treat as lasting.

• Fees and spread earnings are recurring. Asset management fees come from capital that is committed for years, and insurance spread earnings come from annuity liabilities written against assets that the group itself manages. Together they make up about three quarters of segment earnings.
• Carried interest is lumpy. I exclude it from the main earnings base and value it separately, at $0.22 a share in the Base, which equals the average realized over the last twelve months ($520 million over 2,362 million diluted shares). A single large realization can move a quarter, and a cycle without exits can remove it.
• Operating businesses are the least certain part. They send up distributions, but those depend on the cash flow and refinancing of individual infrastructure, power and property assets, and I do not know the distribution capacity of each.

I did not find an audited cash flow figure that matches distributable earnings, so I cannot say what share of it is received in cash in a given year. That is an open data gap, and it is one reason the Confidence grade is C.

Capital, debt and shares

The deployable capital figure is mostly third-party capital that Brookfield invests and charges fees on, not money that belongs to common shareholders. I do not count it as value. Corporate interest and preferred dividends are already deducted from distributable earnings, so I do not subtract the $14.7 billion of corporate debt again in the earnings-based values. I use the diluted count of 2,352.7 million shares for per-share values. The company bought back shares at an average of $42 this year, above the current price of $39.50, which is a reminder that the buyback has not been a bargain-hunting program.

I have not modeled any change to the share structure that management may pursue. If the structure changes, the share count and the per-share earnings must be rebuilt from the new filings.

Primary valuation: distributable earnings to shareholders

The model starts from the $2.39 of distributable earnings before realizations and grows it for ten years. Each year, the cash available to shareholders is the year's earnings minus the capital needed to fund the next year's growth. That capital is the increase in earnings divided by the return on new capital, which I set at 14% in the Base. A terminal value follows year ten, discounted at the cost of equity.

• Base: earnings growth of 13%, 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5% and 4% over ten years, which lifts earnings from $2.39 to $2.70 in year one and $4.03 in year five, a five-year growth rate of 11.0% a year. Cost of equity 11.5%, terminal growth 3.0%, return on new capital 14%.
• Carried interest: valued separately as $0.22 a share, growing at 3% and capitalized at the cost of equity.
• Result: $27.19 for the earnings stream and $2.67 for carried interest, a total of $29.85. The terminal value is 63.5% of the earnings value, over a ten-year explicit horizon.

A terminal share of 63.5% sits below the 75% attention level for a ten-year horizon, so I do not treat it as a defect, but it means that 64 cents of each dollar of value depends on what happens after 2036. The growth path I use is above what the market usually grants a mature company, which reflects the real capital Brookfield raises and invests. It is an estimate, not a reported figure.

Secondary valuation: earnings multiple

The cross-check applies 14 times to distributable earnings before realizations and adds carried interest at 8 times its $0.22 realized level: $33.46 plus $1.76 gives $35.22. The 14 times is not a tier default. It sits below the 16.5 times the market pays and reflects my view that a durable fee base deserves a premium to a plain holding company while the leveraged parent and the growth the Base needs argue against paying more. The multiple is a judgment, and the range from 10 times (Bear) to 18 times (Bull) shows how much of the answer it carries.

The two methods share the same starting earnings and the same view that fee income is stable. They differ in how growth, the return on new capital and the cost of equity are treated. Their agreement therefore says less than it would if the inputs were independent, and I give no extra Confidence for it.

Historical cross-check and growth diagnostic

I did not collect a multi-year multiple history for Brookfield, so I do not claim that the price is above or below its own past average. The historical score is neutral and the data gap is listed in the fine print. What I can say is that fee-related earnings rose 20% year on year in the second quarter, and that my Base path assumes growth of 13%, 12% and 11% in the next three years and a fade after that. One quarter does not tell me whether that pace is sustainable as the fee-bearing capital base gets larger.

I do not use a forward growth-adjusted multiple as a source of value. Growth is classified as structural for fees and spread earnings, and acquisition-affected for operating businesses, because purchases add earnings that are not organic.

Valuation triangulation

• Primary (earnings cash flow model): $29.85, weight 60%.
• Secondary (14 times earnings): $35.22, weight 40%.
• Divergence between the two: 16.5% of their midpoint, inside the 20% limit, so no divergence flag.
• Weighted Base: $32.00. The unweighted range of $29.85 to $35.22 is the honest uncertainty, and $32.00 is a point inside it, not a narrowing of it.

I weight the cash flow model higher because it states its growth and capital needs openly, while the multiple hides them in one number. Both values are below the price, so the choice of weights does not change the verdict.

What is the market already pricing in?

A buyer at $39.50 earns about 11.7% a year only if the Base growth path holds and the market keeps paying 16.5 times. If the multiple moves to the 14 times I use as fair, the return falls below my requirement. The price is therefore a bet on both growth and the multiple.

Bear, base and bull scenarios

• Bear: earnings growth of 5% fading to 3%, cost of equity 12%, terminal growth 2.5%, return on new capital 10%, carried interest of $0.10 a share, 10 times earnings in the cross-check. Fundraising slows and exits dry up.
• Base: as described above.
• Bull: earnings growth of 17% fading to 5%, cost of equity 11%, terminal growth 3.5%, return on new capital 16%, carried interest of $0.30 a share, 18 times earnings in the cross-check.

Even the Bull case is only 6.7% above the price. The price already sits near the top of my range, and the asymmetry is poor: 44% below in the Bear against 7% above in the Bull. The sensitivity below shows the Base cash flow value for different assumptions.

Every cell is below the $39.50 price. The cost of equity matters more than the return on new capital: a one-point change in the cost of equity moves the value by about $4 to $5, and a two-point change in the return on new capital moves it by about $2 to $3. These figures include carried interest.

How the buy price is set

Confidence is C, which calls for a margin of safety of 35% to 50% in my method. I use 35%, the low end, because distributable earnings are largely recurring but come with a heavy dependence on terminal value and on a management-defined profit measure. The margin is applied once, to each method.

The conservative limit is $19.40 and the range is $19.40 to $22.89. A price this far below today's means the buy zone is a re-entry condition after a large drop, not an expected event. If the price ever reaches $19.40, I would first check why. The price is above all three entry values, so the verdict is Hold, not Buy.

Dividend and buybacks

The dividend is $0.07 a quarter, or $0.28 a year, a yield of 0.7%. It takes about 12% of the $2.39 of earnings, so it is safe and also small. Buybacks of about $580 million so far this year are under 1% of the market value and offset little of the share count, because the diluted count still includes share equivalents. Shareholder return comes from reinvestment and the growth of the earnings stream, not from cash paid out.

Reasons to own BN

• Recurring fee and spread earnings are about three quarters of segment earnings, and fee-bearing capital is committed for long periods.
• $210 billion of deployable capital gives room to raise funds and invest through a downturn.
• Fee-related earnings rose 20% year on year in the second quarter, and the Base path assumes growth fades over ten years, not that it continues.
• Realized carried interest of $520 million over twelve months is an upside that the Base values at a modest level.

What could go wrong?

• Fundraising or exits slow, which cuts fees on new capital and removes carried interest.
• Insurance spread earnings are exposed to credit losses and to the performance of the assets that back annuity liabilities.
• $14.7 billion of corporate debt and annual interest of about $0.7 billion need refinancing at acceptable rates.
• The headline measure is management-defined, and its link to cash received is not shown in what I reviewed.
• The price already assumes growth above my Base, so even a small miss can reduce the multiple.

Management execution

• The company holds $210 billion of deployable capital, which shows the franchise can attract and keep capital.
• Repurchases of about $580 million this year were made at an average of $42, above the current price, a small point against timing but not against intent.
• Compensation and carried interest sharing between the parent, the manager and the operating businesses are complex, and I did not audit them.

Stock Analyza scorecard

The valuation score is 37 of 100, which sits in the overvalued band of 25 to 44.

Business quality and valuation are shown separately and are not averaged. A good business at a price above its value is still a hold.

Confidence score

The grade measures how well the model is identified, not the chance of a loss. Several inputs, including the growth path and the return on new capital, are estimates.

What I would watch from here

The three most important thesis breakers

1. Fee-bearing capital stops growing, which removes the base of the 11% growth path.
2. A credit event in the insurance group, which would hit spread earnings and raise the cost of funding.
3. A rise in the cost of equity above 12.5%, which lowers the Base cash flow value to $25.88 or less.

Stress test and independent check

I recomputed the values with a separate script and checked the reverse valuation by bisection. That checks the arithmetic, not the forecasts. The main points the check forced are listed below.

The strongest bull argument is that fee-bearing capital compounds faster than my Base and that carried interest is worth more than $0.22 a share, which would justify the Bull value near today's price. The strongest bear argument is that the earnings measure overstates cash, growth slows as the base gets larger, and the market multiple falls toward 14 times or lower.

Final verdict: hold at $39.50, watchlist for new money

Brookfield is a high-quality, growing collection of fee, insurance and operating earnings, priced above what I think it is worth. At 16.5 times distributable earnings, the price needs both growth and the multiple to hold up, and it offers no margin of safety.

Verdict: HOLD at $39.50, watchlist for new money. Weighted Base $32.00, 19.0% below the price, cross-check $35.22, Confidence C (17/25). Required margin of safety 35%, buy range $19.40 to $22.89, conservative buy limit $19.40.

For an existing holder, the original cost is irrelevant, and nothing here says to sell: the price is inside my Bull range and the business is strong. A review is warranted if the third quarter report on November 12 shows earnings that miss the Base path, or if the price moves well above the Bull value of $42.15 without a change in fundamentals. New money should wait for a price at or below $22.89 and a clearer link from distributable earnings to cash.

Sources

Primary sources are Brookfield Corporation's second quarter 2026 results release and its interim report for the period ended June 30, 2026.

The reference market price is $39.50, the October 29, 2026 regular session close from a public price history, checked against a broker quote of $39.46 on October 30. Balance sheet and earnings figures are as of June 30, 2026 or the twelve months to that date.